← Leaderboards
Karen McLean
University Of Michigan At Ann Arbor
$1,876,587
Attributed
$1,876,587
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $394.5K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,876,587 · 1
By mechanism
R01$1,876,587 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Dean E. Brenner$31,108,993
- Pavan Reddy$35,237,005
- Lynda D Lisabeth$18,344,136
- Yuqing E Chen$44,993,151
- Anthony Rosenzweig$35,493,023
Others in their field
Other Emerging Leaders on “Dna Repair”
- Russell T Hepple · California Pacific Med Ctr Res Institute$6,127,391
- Chongyuan Luo · University Of California Los Angeles$5,685,803
- William Raymond Lagor · Baylor College Of Medicine$5,351,429
- Samuel Henry Sternberg · Columbia University Health Sciences$5,236,150
- James M Dewar · Vanderbilt University$4,949,419
- William H. Peranteau · Children'S Hosp Of Philadelphia$4,881,032
Research focus
Dna RepairCytotoxic ChemotherapyDefectDna DamageApoptoticBiological ModelsBrca1 GeneAnti-Tumor Immune ResponseAurora Kinase ACancer TherapyCancer TypeCarcinomaCell Culture TechniquesCell DeathCell LineCell PhysiologyCellsAurora KinaseCheckpoint ReceptorsCancer EtiologyClinical DevelopmentClinical TrialsCombinatorialDown-Regulation
Grant awards (6)
Sensitizing high grade serous cancers to immunotherapy through the induction of DNA damage$374,836
R01 · FY2024 · CA · contact PI
Sensitizing high grade serous cancers to immunotherapy through the induction of DNA damage$393,522
R01 · FY2023 · CA · contact PI
Sensitizing high grade serous cancers to immunotherapy through the induction of DNA damage$373,561
R01 · FY2022 · CA · contact PI
Sensitizing High Grade Serous Cancers to Immunotherapy through the Induction of DNA Damage$20,968
R01 · FY2022 · CA · contact PI
Sensitizing High Grade Serous Cancers to Immunotherapy through the Induction of DNA Damage$356,850
R01 · FY2021 · CA · contact PI
Sensitizing High Grade Serous Cancers to Immunotherapy through the Induction of DNA Damage$356,850
R01 · FY2020 · CA · contact PI